New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling

Mikael P. Johansson, Hannu Maaheimo, Filip S. Ekholm

Research output: Contribution to journalArticleScientificpeer-review

5 Citations (Scopus)

Abstract

Antibody-drug conjugates (ADCs) are emerging as a promising class of selective drug delivery systems in the battle against cancer and other diseases. The auristatins monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF) appear as the cytotoxic drug in almost half of the state-of-the-art ADCs on the market or in late stage clinical trials. Here, we present the first complete NMR spectroscopic characterisation of these challenging molecules, and investigate their structural properties by a combined NMR and quantum chemical modelling approach. We find that in solution, half of the drug molecules are locked in an inactive conformation, severely decreasing their efficiency, and potentially increasing the risk of side-effects. Furthermore, we identify sites susceptible to future modification, in order to potentially improve the performance of these drugs.

Original languageEnglish
Article number15920
Pages (from-to)15920
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - 21 Nov 2017
MoE publication typeA1 Journal article-refereed

Fingerprint

Nuclear magnetic resonance spectroscopy
Pharmaceutical Preparations
Nuclear magnetic resonance
Molecules
Antibodies
Conformations
Structural properties
auristatin
monomethyl auristatin E

Cite this

@article{81618f9603c14c728ca8afff7167ee81,
title = "New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling",
abstract = "Antibody-drug conjugates (ADCs) are emerging as a promising class of selective drug delivery systems in the battle against cancer and other diseases. The auristatins monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF) appear as the cytotoxic drug in almost half of the state-of-the-art ADCs on the market or in late stage clinical trials. Here, we present the first complete NMR spectroscopic characterisation of these challenging molecules, and investigate their structural properties by a combined NMR and quantum chemical modelling approach. We find that in solution, half of the drug molecules are locked in an inactive conformation, severely decreasing their efficiency, and potentially increasing the risk of side-effects. Furthermore, we identify sites susceptible to future modification, in order to potentially improve the performance of these drugs.",
author = "Johansson, {Mikael P.} and Hannu Maaheimo and Ekholm, {Filip S.}",
year = "2017",
month = "11",
day = "21",
doi = "10.1038/s41598-017-15674-1",
language = "English",
volume = "7",
pages = "15920",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling. / Johansson, Mikael P.; Maaheimo, Hannu; Ekholm, Filip S.

In: Scientific Reports, Vol. 7, No. 1, 15920, 21.11.2017, p. 15920.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling

AU - Johansson, Mikael P.

AU - Maaheimo, Hannu

AU - Ekholm, Filip S.

PY - 2017/11/21

Y1 - 2017/11/21

N2 - Antibody-drug conjugates (ADCs) are emerging as a promising class of selective drug delivery systems in the battle against cancer and other diseases. The auristatins monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF) appear as the cytotoxic drug in almost half of the state-of-the-art ADCs on the market or in late stage clinical trials. Here, we present the first complete NMR spectroscopic characterisation of these challenging molecules, and investigate their structural properties by a combined NMR and quantum chemical modelling approach. We find that in solution, half of the drug molecules are locked in an inactive conformation, severely decreasing their efficiency, and potentially increasing the risk of side-effects. Furthermore, we identify sites susceptible to future modification, in order to potentially improve the performance of these drugs.

AB - Antibody-drug conjugates (ADCs) are emerging as a promising class of selective drug delivery systems in the battle against cancer and other diseases. The auristatins monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF) appear as the cytotoxic drug in almost half of the state-of-the-art ADCs on the market or in late stage clinical trials. Here, we present the first complete NMR spectroscopic characterisation of these challenging molecules, and investigate their structural properties by a combined NMR and quantum chemical modelling approach. We find that in solution, half of the drug molecules are locked in an inactive conformation, severely decreasing their efficiency, and potentially increasing the risk of side-effects. Furthermore, we identify sites susceptible to future modification, in order to potentially improve the performance of these drugs.

UR - http://www.scopus.com/inward/record.url?scp=85034787744&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-15674-1

DO - 10.1038/s41598-017-15674-1

M3 - Article

VL - 7

SP - 15920

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 15920

ER -